{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:54:52Z","timestamp":1771653292554,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Creutzfeldt\u2013Jakob disease (CJD) is lethal and transmissible. We assessed the impact of the COVID\u201019 pandemic on UK CJD surveillance. We hypothesized that (i) disruptions prolonged diagnostic latency; (ii) autopsy rates declined; and (iii) COVID\u201019 infection negatively affected diagnosis, care, and survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively investigated the first year of the pandemic, using the preceding year as a comparator, quantifying numbers of individuals assessed by the UK National CJD Research &amp; Surveillance Unit for suspected CJD, time to diagnosis, disease duration, and autopsy rates. We evaluated the impact of COVID\u201019 status on diagnosis, care, and survival in CJD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 148 individuals were diagnosed with CJD in the pandemic (from a total of 166 individuals assessed) compared to 141 in the comparator (from 145 assessed). No differences were identified in disease duration or time to diagnosis. Autopsy rates were unchanged. Twenty individuals had COVID\u201019; 60% were symptomatic, and 10% had severe disease. Disruptions in diagnosis and care were frequently identified. Forty percent of COVID\u201019\u2010positive individuals died; however, COVID\u201019 status did not significantly alter survival duration in CJD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The COVID\u201019 pandemic has not impacted UK CJD case ascertainment or survival, but diagnostic evaluation and clinical care of individuals have been affected.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ene.15228","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T15:37:33Z","timestamp":1640273853000},"page":"1222-1226","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of the COVID\u201019 pandemic on Creutzfeldt\u2013Jakob disease surveillance and patient care in the United Kingdom"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-4643","authenticated-orcid":false,"given":"Neil","family":"Watson","sequence":"first","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Kirby","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Kurudzhu","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Leitch","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaire","family":"Smith\u2010Bathgate","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Smith","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Summers","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J. E.","family":"Green","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvankar","family":"Pal","sequence":"additional","affiliation":[{"name":"The National CJD Research &amp; Surveillance Unit Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00488-7"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117221"},{"key":"e_1_2_10_4_1","unstructured":"Creutzfeldt\u2010Jakob Disease International Surveillance Network.Diagnostic criteria for surveillance of CJD from 1 January 2017. Updated 2021. Accessed June 23 2021.https:\/\/www.eurocjd.ed.ac.uk\/node\/833"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa240"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2016-001571"},{"key":"e_1_2_10_7_1","unstructured":"Public Health EnglandPublic health action following a report of a new case of CJD or a person at increased risk of CJD. 2015. Accessed May 2021.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/474338\/CJD_public_health_action_new_case_301015.pdf"},{"issue":"2","key":"e_1_2_10_8_1","first-page":"510","article-title":"Rapidly progressive dementia","volume":"22","author":"Geschwind MD","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp191"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00527-1"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.04.019"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.07.007"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6306"},{"key":"e_1_2_10_15_1","unstructured":"National CJD Research & Surveillance Unit28th annual report 2019. Creutzfeldt\u2010Jakob disease surveillance in the UK. 2020. Accessed June 1 2021.https:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/Report28.pdf"},{"key":"e_1_2_10_16_1","unstructured":"Unit NCRS29th annual report 2020. Creutzfeldt\u2010Jakob disease surveilance in the UK. 2021. Accessed October 1 2021.https:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/report29.pdf"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241536"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26326"},{"key":"e_1_2_10_19_1","unstructured":"Government UCoronavirus (COVID\u201019) in the UK. 07\/06\/2021. Accessed June 7 2021.https:\/\/coronavirus.data.gov.uk\/details\/cases"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ene.15228","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T22:57:35Z","timestamp":1693004255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.15228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/ene.15228"],"URL":"https:\/\/doi.org\/10.1111\/ene.15228","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2021-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}